2019 Technical Fellowship Awardees
-
Dr. Siew Yim Loh, University of Malaya, Kuala Lumpur, Malaysia
Host Institution: University of Southampton, Southampton, United Kingdom
Patient support, survivorship and palliative care at Macmillan Research Centre
......................................................
Syed Jawad Ali Shah, Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan
Host Institution: CancerCare Manitoba, Manitoba, Canada
Volumetric Modulated Arc Therapy (VMAT) Planning for Head and Neck Cancers
......................................................
Dr. Haydee Cristina Verduzco-Aguirre, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico
Host Institution: University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, United States
Research Observership in Geriatric Oncology
......................................................
Ms. Florence Manjuh, Cameroon Baptist Convention Health Services, Younde, Cameroon
Host Institution: Information and Research Center - King Hussein Foundation, Amman, Jordan
Setting up a Breast cancer program within the CBCHS in Cameroon
......................................................
Mr. Mbiydzenyuy Ferdinant Sonyuy, Cameroon Baptist Convention Health Services, Younde, Cameroon
Host Institution: Information and Research Center - King Hussein Foundation, Amman, Jordan
Setting up a comprehensive Breast Cancer Program in Cameroon
......................................................
Dr Anindita Dutta, Tata Medical Center, Kolkata, India
Host Institution: University of Manchester, Manchester, United Kingdom
Understanding Optimal Conditions For Establishing Reproducible Primary Tumour Organoid
......................................................
Dr Eudoxia Hatzivassiliou, Aristotle University of Thessaloniki, Thessaloniki, Greece
Host Institution: Hubrecht Institute, Utrecht, Netherlands
Investigation of the role of tumor suppressor CYLD in human breast cancer
......................................................
Ijeoma Uzoma, College of Medicine, University of Nigeria, Enugu, Nigeria
Host Institution: University of Siena, Siena, Italy
Immunohistochemical characterisation and genomic profiling of lymphomas in Nigeria
......................................................
Dr. Manit Gundavda, PD Hinduja National Hospital, Mumbai, India
Host Institution: The Royal Orthopaedic Hospital, Birmingham, United Kingdom
High Prevalence of Vitamin D Deficiency in Patients with Bone Tumors: Genomic profiling of Vitamin D Receptor (VDR)
......................................................
Dr Tala Shekarian, University Hospital Basel, Basel, Switzerland
Host Institution: Stanford University School of Medicine, California, United States
High-dimensional analysis of microglial drug response in glioblastoma bioreactors
......................................................
Dr. Fernanda Oliveira, A.C. Camargo Cancer Center, São Paulo, Brazil
Host Institution: Sylvester Comprehensive Cancer Center/University of Miami Health Systems, Miami, United States
Cancer drug incremental cost-effectiveness: systematic review and meta-analysis
......................................................
Dr Razinah Sharif, Universiti Kebangsaan Malaysia, Malaysia
Host Institution: International Agency for Research on Cancer, Lyon, France
Transfer of knowledege and skill needed in metabolomics profiling and cancer mediators for colorectal cancer survivors in Malaysia
......................................................
Ms Swapna Lilly Cyriac, KIMS Cancer Care and Research Center, Trivandrum, India
Host Institution: Northwell Health Center for Advanced Medicine (CFAM), New York, United States
SBRT Planning: A Focus on Treatment Techniques and its Dosimetric Aspects
......................................................
Dr. Filippo Piccinini, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
Host Institution: Biological Research Centre of the Hungarian Academy of Sciences, Szeged, Hungary
3D-CELL-ANNOTATOR for single-cell phenotyping of cancer 3D spheroids
......................................................
Dr. Shubham Garg, Max Superspeciality Hospital, Ghaziabad, India
Host Institution: The Pulmonary Hospital, Zakopane, Poland
Transcervical Approach to Staging and Management of Lung Cancer
......................................................
Dr. Ahmed Abugharib, Sohag Faculty of Medicine, Egypt
Host Institution: Centre Leon Berard, Lyon, France
Molecular imaging using 18FDG-PET/CT for radiation therapy planning of head and neck cancers
......................................................
Dr. Aymone Gurtner, Regina Elena National Cancer Institute, Rome, Italy
Host Institution: Institute of Cancer Research, London, United Kingdom
Set-up and use of Patient-Derived Organoid to identify prognostic biomarkers
......................................................
Dr. Ahmed Mohamed Abdelaziz Abdellatif, Medical Research Institute Alexandria University, Alexandria, Egypt
Host Institution: George Washington University, Washington DC, United States
Innovative surgical management of thoracic malignancies observership
......................................................
Dr Naveen Khargekar, Homi Bhabha Cancer Hospital, Varanasi, India
Host Institution: National Cancer Institute, NIH NCI Division of Cancer Epidemiology and Genetics, Rockville, United States
Individual mentorship training on cervical cancer etiology, biology, screening and precancer treatment
......................................................
Dr Muibat Haruna, Lagos University Teaching Hospital, Lagos, Nigeria
Host Institution: Queen Elizabeth Hospital, Birmingham, United Kingdom
Androgen receptor expression in triple negative breast cancer at the Lagos University Teaching Hospital
......................................................
Dr. Slava Kopetskyi, National Cancer Institute MPH of Ukraine
Host Institution: Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom
Development of peritoneal carcinomatosis treatment program in low-middle income country
......................................................
Dr Mayur Mayank, Apollo Hospital Bangalore, Bangalore, India
Host Institution: Petermac MacCallum Cancer Centre, Melbourne, Australia
SABR in Oligometastatic Disease
......................................................
Dr. Alvaro Ronco, Instituto de Radiología y Centro de Lucha Contra el Cáncer, Montevideo, Uruguay
Host Institution: Instituto de Salud Carlos III de Madrid, Spain
Dietary iron types and breast cancer risk in the MCC-Spain Study
......................................................
Dr Srabani Mittal, Cancer Foundation of India, Kolkata, India
Host Institution: International Agency for Research on Cancer, Lyon, France
Preparation of an online digital atlas on VIA and ablative treatment, and creation of an image library to support development of artificial intelligence in visual detection of cervical abnormalities
......................................................
Dr Anthonia Sowunmi, University Of Lagos, Lagos, Nigeria
Host Institution: The University of Chicago, Chicago, United States
Experiential study of breast cancer clinical trials in a tertiary institution (University of Chicago)
......................................................
Mr. Biswajoy Pal, Tata Medical Center, Kolkata, India
Host Institution: Imperial College London, London, United Kingdom
Molecular diagnosis and monitoring of BCR-ABL positive leukemia
......................................................
Dr. Chantal Matar, University of Ottawa, Canada
Host Institution: International Agency for Research on Cancer, Lyon, France
Chemoprevention signature of probiotics in microbiome regulation of microRNAs expression in the gut and the mammary gland: link between early manipulation of gut microbiome and breast cancer.
......................................................
Dr Seema Singhal, All India Institute of Medical Sciences, New Delhi, India
Host Institution: Memorial Sloan-Kettering Cancer Center, New York, United States
Sentinel lymph node mapping in patients with Endometrial carcinoma
......................................................
Dr Dillip Muduly, All India Institute of Medical Sceinces, Bhubaneswar, India
Host Institution: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Methods of Cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy (HIPEC) for Peritoneal Carcinomatosis (PC)
......................................................
Dr Katarina Rejlekova, National Cancer Institute, Comenius University, Bratislava, Slovak Republic
Host Institution: Memorial Sloan Kettering Cancer Center, New York, United States
Choriocarcinoma syndrome in testicular germ cell tumors
......................................................
Dr. Deep Shankar Pruthi, Action Cancer Hospital, New Dehli, India
Host Institution: Jules Bordet Institute, Brussels, Belgium
Stereotactic Radiotherapy for management of thoracic and CNS malignancies
......................................................
Dr. Lateef Adebisi Odukoya, Lagos University Teaching Hospital, Lagos, Nigeria
Host Institution: University of Chicago, Chicago, United States
Immunohistochemical study and clinicopathologic correlation of COX-2 and HER-2 expression in colorectal carcinoma: a 5-year retrospective study
......................................................
Dr Shagun Misra, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India
Host institution: University of Pennsylvania, Philadelphia, United States
Identifying challenges and setting up a SBRT programme in liver tumors at a tertiary care institution
......................................................
Dr Andreea Marza, Clinic of Pulmonary Diseases, Iasi, Romania
Host Institution: Civil Hospital of Brescia, Brescia, Italy
Developing diagnostic skills in pleural biopsy for pleural tumors management
......................................................
Dr Bindu Krishnappa Venugopal, Kidwai Cancer Institute, Bengaluru, India
Host Institution: Petermac MacCallum Cancer Centre, Melbourne, Australia
To learn and implement stereotactic ablative radiation therapy in the treatment of lung cancer
......................................................
Mr Tarek Mohamed Zaghloul, Children's Cancer Hospital Egypt, Cairo, Egypt
Host Institution: St. Jude Children’s Research Hospital, Memphis, United States
Laparoscopic Surgical Managment of Pediatric Tumours
......................................................
Dr Vipul Nautiyal, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India
Host Institution: Christie School of Oncology, Manchester, United Kingdom
Re-irradiation of head and neck cancer in the era of Advance technique (IMRT, IGRT & SBRT): patient selection, imaging, technical aspects and current evidence
......................................................
Dr JC Kennetth Jacinto, Benavides Cancer Institute, University of Santo Toma, Manila, Philippines
Host Institution: H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Holistic Management of Head and Neck Cancers through Multidisciplinary Approach
......................................................
Mr Saad Bin Saeed Ahmed, Aga Khan University, Pakistan
Host Institution: Hokkaido University Hospital, Sapporo, Japan
Acquiring skills and knowledge on modern treatment planning and delivery techniques in radiotherapy
......................................................
Dr Fan Chai, First Hospital of Army Medical University, Chongqing, China
Host Institution: Organisation for Oncology and Translational Research, Hong Kong
The application and translational research of targeted drugs in advanced breast cancer
......................................................
Dr Jian Chen, Hubei Cancer Hospital, Wuhan, China
Host Institution: National Cancer Institute, Center for Cancer Research, Bethesda, United States
Preclinical experiments and techniques in head and neck cancer models
......................................................
Dr Jiangyuan Yu, Peking University Cancer Hospital & Institut, Beijing, China
Host Institution: Zentralklinik Bad Berka, Bad Berka, Germany
Clinical application of peptide receptor radionuclide therapy in neuroendocrine neoplasms
......................................................
Dr Yubei Huang, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Host Institution: International Agency for Research on Cancer (IARC), Lyon, France
Cross-sectional studies on the associations between cancer screening beliefs, knowledge, mental health, and behaviors
......................................................
Dr Jing Liu, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Host Institution: University Health Network, Toronto, Canada
Clinical Observership of Breast Reconstruction
......................................................
Dr Jun Li, Henan Cancer Hospital, Zhengzhou, China
Host Institution: Mayo Clinic, Rochester, United States
BRCA pathogenic mutations in the progenitor cells contribute to the carcinogenesis, treatment response and prognosis of ovarian cancer
......................................................
Dr Yuanyuan Lu, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China
Host Institution: Vanderbilt University Medical Center (VUMC), Nashville, United States
Mechanisms of Epigenetic Regulation of Drug Resistance in Cancer
......................................................
Dr Xiaolei Wei, Nanfang Hospital, Southern Medical University, Guangzhou, China
Host Institution: Center for Genomic Regulation, Barcelona, Spain
xCT Inhibition Confers Chemoresistance in the ABC Subtype of Diffuse Large B cell lymphoma
......................................................
Dr Yiming Meng, Liaoning Province Cancer Hospital, Shenyang, China
Host Institution: Johns Hopkins University-School of Medicine, Baltimore, United States
Weakening the extent of the damage of chemotherapy drugs on nerve cells
......................................................
Dr Akhilanand Chaurasia, King George's Medical University, Lucknow, India
Host Institution: Guy's, King's and St Thomas, school of Medicine and Dentistry, London, United Kingdom
A comparative evaluation of circulatory and salivary miRNA’s as diagnostic biomarkers in Precancerous and Cancerous Lesions of Oral Cavity-A prospective case control study
......................................................
Dr Kavitha Jain, Tata Memorial Centre, Mumbai, India
Host Institution: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
Clinical fellowship/observership - cancer treatment - multidisciplinary management of soft tissue sarcomas
......................................................
Dr Soniya Dulal, National Academy of Medical Sciences, Kathmandu, Nepal
Host Institution: Princess Margaret Cancer Centre, Toronto, Canada
Multidisciplinary management of advanced/ incurable lung cancer
......................................................
Mr Lambert Christophe Safari, Muhimbili University Health and Allied Sciences, Dar-Es-Salaam, Tanzania
Host Institution: University of California, San Francisco, United States
Acquiring advanced skills in supportive care delivery to improve quality of life in cancer patients
......................................................
Dr Suraj Hindiskere, HCG Cancer Centre, Bangalore, India
Host Institution: Istituto Ortopedico Rizzoli, Bologna, Italy
Fellowship in Orthopaedic Oncology
......................................................
Dr Arun Pandey, Geetanjali Medical College and Hospital, Udaipur, India
Host Institution: Memorial Sloan Kettering Cancer Center, New York, United States
Hepatobiliary Cancer Surgery Observership
......................................................
Dr Kunal Oswal, Tata Education Development Trusts, Mumbai, India
Host Institution: International Agency for Research on Cancer, Lyon, France
UICC- IARC Development Fellowship: Evaluation of breast, cervix and oral cancer screening policies and implementation in India
......................................................
Mr Rongshou Zheng, National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Host Institution: International Agency for Research on Cancer, Lyon, France
UICC-IARC Development Fellowship: Assessing the impact of risk factor changes and population aging on future cancer burden in China
......................................................
Dr Ivana Blazic, Clinical Hospital Center Zemun, Belgrade, Serbia
Host Institution: Instituto Alexander Fleming, Buenos Aires, Argentina
Epidemiological, pathological, clinical and imaging features of colorectal cancer in young adults
......................................................
Dr Sudha Padmam, Regional Cancer Centre, Trivandrum, India
Host Institution: Cancer Treatment Centers of America , Tulsa, United States
Safer and nonaddictive cancer pain management in the current era of opioid epidemic in cancer patients
......................................................
Eveline Tata Mayaah, Humanity at Heart International Association, Douala, Cameroon
Host Institution: Women4cancer early detection and treatment, Nairobi, Kenya
Public health: Cancer Prevention and Advocacy
......................................................
Dr María Graciela Abriata, Agency for Cancer Control of Santa Fe, Rosario, Argentina
Host Institution: International Agency for Research on Cancer, Lyon, France
UICC-IARCDEVFEL – Improving cancer surveillance in Latin America through tailored training material and status analysis
......................................................
Last update
Thursday 12 January 2023